Diagnostics Opens up new avenues for the Shigella Test Kit Market
![]() |
Shingella Test Kits Market |
The global Shigella Test Kit
Market is estimated to be valued at US$
106.4 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market Overview:
Shigella test kits are diagnostic
tools used to detect the presence of Shigella bacteria in stool samples
collected from patients experiencing symptoms of shigellosis. They help doctors
prescribe the right treatment by confirming or ruling out the infection.
Shigella test kits offer quick and accurate results, enabling timely treatment
of the disease.
Market key trends:
Rise in digital therapeutics -
Digital therapeutics refers to evidence-based therapeutic interventions
designed to prevent, manage, or treat a medical condition. Companies are
focusing on developing digital diagnostic and testing tools like
smartphone-based rapid test kits and portable lab devices connected to
telehealth platforms. This allows remote monitoring of patients and early detection
of diseases like shigellosis. The increasing adoption of such novel digital
solutions is expected to propel the growth of the shigella test kit market over
the forecast period.
Segment Analysis
The Shigella test kit market is
segmented based on product into immunoassay test kits and PCR test kits. Among
these, the immunoassay test kits segment held the largest market share in 2022.
This is because immunoassay test kits have higher adoption rate as they are
simple to use, require less time to perform the test and generate quick results
as compared to PCR test kits. However, the PCR test kits segment is expected to
grow at a higher CAGR during the forecast period due to high accuracy and
sensitivity offered by PCR tests.
Key Takeaways
The global
Shigella test kit market is expected to witness high growth, exhibiting
CAGR of 5.9% over the forecast period, due to increasing prevalence of
shigellosis. According to WHO, shigellosis causes high medical costs due to
treatment costs and loss in productivity. Therefore, increasing awareness
regarding shigellosis is driving the adoption of test kits.
Regional analysis - North America
dominated the global market in 2022 owing to supportive initiatives by US
government and presence of major players. Asia Pacific is expected to grow at
the highest CAGR during the forecast period due to rapidly developing
healthcare infrastructure and increasing spending on healthcare in Asian
countries.
Key players - Key players operating in the Shigella test kit market
are Thermo Fisher Scientific Inc., Meridian Bioscience Inc., QIAGEN N.V.,
Bio-Rad Laboratories Inc., Creative Diagnostics, Hardy Diagnostics, Luminex
Corporation, DiaSorin S.p.A., Sekisui Diagnostics LLC, BioMérieux SA, MP
Biomedicals LLC, Coris BioConcept, Alere Inc., Fujirebio Diagnostics Inc., CTK
Biotech Inc. These players are focusing on new product launches and geographic
expansion to increase their market share.
Read more
https://www.dailyprbulletin.com/shigella-test-kit-market-size-share-growth-outlook-2023/
Comments
Post a Comment